SUMMARY A total of 438 strains of Pseudomonas aeruginosa supplied by 10 hospitals in the UK reporting an increase in resistance to carbenicillin was tested for sensitivity to carbenicillin and ticarcillin. It was found that 85 % of the strains were inhibited by 125 ,g carbenicillin/ml and 87 % by 50 ,g ticarcillin/ml, and that ticarcillin was from two-to four-fold more active than carbenicillin against the majority of these strains. Strains with a high level of resistance to carbenicillin (MIC > 1000 ,ug/ml) possessed constitutive fl-lactamases, and five different types of enzyme were identified. There was good correlation between minimum inhibitory concentrations and the results of disc sensitivity tests in this study, 82% with the 100 ,g carbenicillin disc and 90% with the 75 ,ug ticarcillin disc, but results reported in the hospital laboratory tests with the carbenicillin disc were less satisfactory (64% correlation). From a comparison with data reported in 1967 there does not appear to have been a significant increase in the incidence of carbenicillin-resistant strains of Ps aeruginosa in the UK.
The development of resistant strains of Pseudomonas aeruginosa during treatment with carbenicillin' and the emergence of strains with a high level of resistance2 were reported relatively soon after the introduction of the broad-spectrum penicillin into clinical practice in 1967. Not Although the overall incidence of resistance to carbenicillin (15%) and ticarcillin (13 %) remained low there was considerable variation in the proportion of resistant strains in the individual hospitals (Table 3 ). In most cases the incidence of resistance 299 It is of interest that the cultures tested here were supplied by 10 hospitals thought to have experienced an increase in the incidence of carbenicillin-resistant isolates of Ps aeruginosa, although in fact the overall level of resistance was found not to be high, being no more than 10-20% of the strains supplied by the majority of hospitals. It may be that the batches of isolates tested were unrepresentative, but it could also be that there are problems in sensitivity testing, as is evidenced by the fact that only 64% of the strains inhibited by 125 jg carbenicillin/ml were classified as being sensitive to carbenicillin on the basis of hospital disc sensitivity tests. There are difficulties in testing the sensitivity ofPsaeruginosa to carbenicillin as carbenicillin sensitivity discs are relatively unstable and readily inactivated unless the correct storage conditions are used,14 and a large inoculum yields small inhibition zones, possibly with apparently resistant colonies. 15 Another factor that may contribute is that PsaeruginosaNCTC 10662, the control strain recommended in the UK, may be more sensitive to carbenicillin than are many isolates that may be considered clinically sensitive (MIC < 125 gg/ml). For instance, the culture of Ps aeruginosa NCTC 10662 used in this study was inhibited in eight out of 10 tests by 25 ,ug carbenicillin/ml, and consequently a number of strains with MIC values of 50-125 ,ug carbenicillin/ml were classified as being only moderately sensitive.
The opportunity was also taken in this study to test these recent clinical isolates for sensitivity to ticarcillin, and the results of the tests confirmed that ticarcillin was two to four times more active than carbenicillin against the majority of strains tested. 5 Strains with an increased level of resistance to carbenicillin usually showed a similar increase in resistance to ticarcillin, and those strains with a high level of resistance to carbenicillin were equally resistant to ticarcillin. In the disc sensitivity tests, there was rather better correlation between minimum inhibitory concentrations and the results of the disc tests with the 75 ,ug ticarcillin disc than with the 100ug carbenicillin disc, in keeping with reports from the USA.16 17 
